Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare PBMs Could Offer "Loose" And "Tight" Rx Options - Rep. Johnson

Executive Summary

The number of prescription plan choices under Medicare could be doubled by requiring competing pharmacy benefit managers to offer both high- and low-premium drug benefits, House Ways & Means/Health Subcommittee Chairwoman Johnson (R-Conn.) suggested during a March 27 hearing.

You may also be interested in...



Medicare Rx: Rep. Johnson To Introduce Drug/Reform Bill In 2002

The Medicare prescription drug benefit debate in 2002 will kick off in the House with the expected introduction of a bill by Rep. Nancy Johnson (R-Conn.)

Medicare Rx: Rep. Johnson To Introduce Drug/Reform Bill In 2002

The Medicare prescription drug benefit debate in 2002 will kick off in the House with the expected introduction of a bill by Rep. Nancy Johnson (R-Conn.)

Medicare Disease Management Could End Need For Rx Benefit-CBO's Crippen

A disease management program that includes prescription drug coverage could eliminate the need for a universal prescription drug benefit, Congressional Budget Office Director Dan Crippen suggested.

Related Content

UsernamePublicRestriction

Register

PS037594

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel